Xiang Xiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xiang Xiao has a total of 169 co-authors. Here are the top co-authors by number of shared publications:
- Xian Chang Li
Immunobiology and Transplant Science Center and Department of Surgery, Houston Methodist Hospital, Texas Medical Center, Houston, TX
28 shared publications - Wenhao Chen
Immunobiology & Transplant Science Center, Department of Surgery, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, USA
10 shared publications Gulcin Demirci
Transplant Research Center, the Brigham and Women’s Hospital and Children’s Hospital Boston, Harvard Medical School, Boston, MA 02115
7 shared publicationsWentao Liu
Immunobiology & Transplant Science Center, Houston Methodist Hospital, Texas Medical Center, Houston, TX 77030, USA
7 shared publicationsPeixiang Lan
Department of Surgery, Immunobiology and Transplant Science Center, Houston Methodist Research Institute and Institute for Academic Medicine, Houston Methodist Hospital, Houston, USA
6 shared publicationsLaurie Minze
Immunobiology & Transplant Science Center, Houston Methodist Hospital, Texas Medical Center, Houston, TX, USA
5 shared publications
Latest Publications
- Open Access
- 31 October 2026
- Published by Springer Nature in Nature Communications
A stem-like CD8+ T cell reservoir resists exhaustion and sustains alloimmunity a decade after transplantation
Chronic antigen exposure is commonly thought to drive CD8 + T cells toward exhaustion. However, in transplantation, we show that sustained immunity is maintained by a persistent stem-like reservoir that iteratively replenishes short-lived cytotoxic effectors rather than progressing toward exhaustion. Analysis of rejected human kidney allografts obtained approximately 10 years after transplantation reveals extensive overlap of CD8 + T-cell clonotypes between the circulation and allografts. These clones are maintained in a TCF1 + stem-like state in the circulation but differentiate into TCF1 − cytotoxic effectors within allografts. Mouse models demonstrate that cytotoxic effector differentiation is restrained by TCF1 and depends on lactate dehydrogenase A. Cytotoxic effectors are short-lived and insufficient to mediate allograft rejection upon transfer into secondary hosts, whereas stem-like T cells retain self-renewal capacity, continuously replenish cytotoxic effectors, and drive rejection across serial transplantations. These findings establish a principle whereby a stem-like CD8 + T-cell reservoir drives sustained alloimmunity through continuous effector differentiation.
- 31 October 2026
- Published by Springer Nature in Nature Communications
Open AccessA stem-like CD8+ T cell reservoir resists exhaustion and sustains alloimmunity a decade after transplantation
Chronic antigen exposure is commonly thought to drive CD8 + T cells toward exhaustion. However, in transplantation, we show that sustained immunity is maintained by a persistent stem-like reservoir that iteratively replenishes short-lived cytotoxic effectors rather than progressing toward exhaustion. Analysis of rejected human kidney allografts obtained approximately 10 years after transplantation reveals extensive overlap of CD8 + T-cell clonotypes between the circulation and allografts. These clones are maintained in a TCF1 + stem-like state in the circulation but differentiate into TCF1 − cytotoxic effectors within allografts. Mouse models demonstrate that cytotoxic effector differentiation is restrained by TCF1 and depends on lactate dehydrogenase A. Cytotoxic effectors are short-lived and insufficient to mediate allograft rejection upon transfer into secondary hosts, whereas stem-like T cells retain self-renewal capacity, continuously replenish cytotoxic effectors, and drive rejection across serial transplantations. These findings establish a principle whereby a stem-like CD8 + T-cell reservoir drives sustained alloimmunity through continuous effector differentiation.
- Open Access
- 21 July 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (10) , 2067-2081
Epigenetically modulating macrophage subpopulations to promote long-term allograft survival in a mouse heart transplant model
- 21 July 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (10) , 2067-2081
Open AccessEpigenetically modulating macrophage subpopulations to promote long-term allograft survival in a mouse heart transplant model
- 16 June 2025
- Published by Springer Nature in Nature Immunology
- Vol. 26 (7) , 1062-1073
IRF4 expression by NK precursors predetermines exhaustion of NK cells during tumor metastasis
Natural killer (NK) cells are essential for controlling tumor metastasis, but their protective capacity diminishes when entering an exhaustion state. The mechanisms underlying NK cell exhaustion are incompletely understood. Here, we show that the susceptibility of NK cells to exhaustion is predetermined early during their development and is governed by the transcription factor IRF4. Notably, IRF4 is highly expressed in CD27−CD24+ NK precursors but is nearly absent in immature and mature NK cells. Deletion of IRF4 redirects NK cell development, enabling NK precursors to generate more mature NK cells that resist exhaustion, thereby decreasing melanoma lung metastasis. This resistance to exhaustion is evident by increased effector molecule production and decreased expression of inhibitory receptors such as TIGIT and Pik3ip1. Deleting Pik3ip1 also enhances NK cell ability to counteract melanoma lung metastasis. These findings enhance our understanding of NK cell exhaustion and have implications for preventing cancer metastasis using NK cells.
- 16 June 2025
- Published by Springer Nature in Nature Immunology
- Vol. 26 (7) , 1062-1073
IRF4 expression by NK precursors predetermines exhaustion of NK cells during tumor metastasis
Natural killer (NK) cells are essential for controlling tumor metastasis, but their protective capacity diminishes when entering an exhaustion state. The mechanisms underlying NK cell exhaustion are incompletely understood. Here, we show that the susceptibility of NK cells to exhaustion is predetermined early during their development and is governed by the transcription factor IRF4. Notably, IRF4 is highly expressed in CD27−CD24+ NK precursors but is nearly absent in immature and mature NK cells. Deletion of IRF4 redirects NK cell development, enabling NK precursors to generate more mature NK cells that resist exhaustion, thereby decreasing melanoma lung metastasis. This resistance to exhaustion is evident by increased effector molecule production and decreased expression of inhibitory receptors such as TIGIT and Pik3ip1. Deleting Pik3ip1 also enhances NK cell ability to counteract melanoma lung metastasis. These findings enhance our understanding of NK cell exhaustion and have implications for preventing cancer metastasis using NK cells.
- Open Access
- 31 December 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (4)
Apex1 safeguards genomic stability to ensure a cytopathic T cell fate in autoimmune disease models
T cells have a remarkable capacity to clonally expand, a process that is intricately linked to their effector activities. As vigorously proliferating T cell also incur substantial DNA lesions, how the dividing T cells safeguard their genomic integrity to allow the generation of T effector cells remains largely unknown. Here we report the identification of the apurinic/apyrimidinic endonuclease-1 (Apex1) as an indispensable molecule for the induction of cytopathic T effectors in mouse models. We demonstrate that conditional deletion of Apex1 in T cells resulted in a remarkable accumulation of baseless DNA sites in the genome of proliferating T cells, which further led to genomic instability and apoptotic cell death. Consequently, Apex1- deleted T cells failed to acquire any effector features after activation and failed to mediate autoimmune diseases and allergic tissue damages. Detailed mutational analyses pinpointed the importance of its endonuclease domain in the generation of T effector cells. We provide further evidence that inhibiting the base repair activities of Apex1 with chemical inhibitors similarly abrogated the induction of autoimmune diseases. Collectively, our study suggests that Apex1 serves as a gatekeeper for the generation of cytopathic T cells and that therapeutically targeting Apex1 may have important clinical implications in the treatment of autoimmune diseases.
- 31 December 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (4)
Open AccessApex1 safeguards genomic stability to ensure a cytopathic T cell fate in autoimmune disease models
T cells have a remarkable capacity to clonally expand, a process that is intricately linked to their effector activities. As vigorously proliferating T cell also incur substantial DNA lesions, how the dividing T cells safeguard their genomic integrity to allow the generation of T effector cells remains largely unknown. Here we report the identification of the apurinic/apyrimidinic endonuclease-1 (Apex1) as an indispensable molecule for the induction of cytopathic T effectors in mouse models. We demonstrate that conditional deletion of Apex1 in T cells resulted in a remarkable accumulation of baseless DNA sites in the genome of proliferating T cells, which further led to genomic instability and apoptotic cell death. Consequently, Apex1- deleted T cells failed to acquire any effector features after activation and failed to mediate autoimmune diseases and allergic tissue damages. Detailed mutational analyses pinpointed the importance of its endonuclease domain in the generation of T effector cells. We provide further evidence that inhibiting the base repair activities of Apex1 with chemical inhibitors similarly abrogated the induction of autoimmune diseases. Collectively, our study suggests that Apex1 serves as a gatekeeper for the generation of cytopathic T cells and that therapeutically targeting Apex1 may have important clinical implications in the treatment of autoimmune diseases.
- Open Access
- 8 December 2022
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 7 (23)
Ox40-Cre–mediated deletion of BRD4 reveals an unexpected phenotype of hair follicle stem cells in alopecia
BRD4 is a bromodomain extraterminal domain family member and functions primarily as a chromatin reader regulating genes involved in cell-fate decisions. Here, we bred Brd4 fl/fl Ox40-Cre mice in which Brd4 was conditionally deleted in OX40-expressing cells to examine the role of BRD4 in regulating immune responses. We found that the Brd4 fl/fl Ox40-Cre mice developed profound alopecia and dermatitis, while other organs and tissues were not affected. Surprisingly, lineage-tracing experiments using the Rosa26 fl/fl -Yfp mice identified a subset of hair follicle stem cells (HFSCs) that constitutively express OX40, and deletion of Brd4 specifically in such HFSCs resulted in cell death and a complete loss of skin hair growth. We also found that death of HFSCs triggered massive activation of the intradermal γδ T cells, which induced epidermal hyperplasia and dermatitis by producing the inflammatory cytokine IL-17. Interestingly, deletion of Brd4 in Foxp3 + Tregs, which also constitutively express OX40, compromised their suppressive functions, and this, in turn, contributed to the enhanced activation of γδ T cells, as well as the severity of dermatitis and hair follicle destruction. Thus, our data demonstrate an unexpected role of BRD4 in regulating skin follicle stem cells and skin inflammation.
- 8 December 2022
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 7 (23)
Open AccessOx40-Cre–mediated deletion of BRD4 reveals an unexpected phenotype of hair follicle stem cells in alopecia
BRD4 is a bromodomain extraterminal domain family member and functions primarily as a chromatin reader regulating genes involved in cell-fate decisions. Here, we bred Brd4 fl/fl Ox40-Cre mice in which Brd4 was conditionally deleted in OX40-expressing cells to examine the role of BRD4 in regulating immune responses. We found that the Brd4 fl/fl Ox40-Cre mice developed profound alopecia and dermatitis, while other organs and tissues were not affected. Surprisingly, lineage-tracing experiments using the Rosa26 fl/fl -Yfp mice identified a subset of hair follicle stem cells (HFSCs) that constitutively express OX40, and deletion of Brd4 specifically in such HFSCs resulted in cell death and a complete loss of skin hair growth. We also found that death of HFSCs triggered massive activation of the intradermal γδ T cells, which induced epidermal hyperplasia and dermatitis by producing the inflammatory cytokine IL-17. Interestingly, deletion of Brd4 in Foxp3 + Tregs, which also constitutively express OX40, compromised their suppressive functions, and this, in turn, contributed to the enhanced activation of γδ T cells, as well as the severity of dermatitis and hair follicle destruction. Thus, our data demonstrate an unexpected role of BRD4 in regulating skin follicle stem cells and skin inflammation.
- 1 February 2020
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 39 (2) , 134-144
T follicular helper and memory cell responses and the mTOR pathway in murine heart transplantation
- 1 February 2020
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 39 (2) , 134-144
T follicular helper and memory cell responses and the mTOR pathway in murine heart transplantation
- Open Access
- 15 August 2019
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 203 (4) , 873-880
Identification of the E3 Ligase TRIM29 as a Critical Checkpoint Regulator of NK Cell Functions
NK cells play an important role in immune surveillance and protective immunity, mainly through rapid cytokine release and cytolytic activities. But how such responses are negatively regulated remains poorly defined. In this study, we demonstrated that the E3 ubiquitin ligase TRIM29 is a crucial regulator of NK cell functions. We found that TRIM29 was not expressed in resting NK cells, but was readily upregulated following activation, especially after IL-12 plus IL-18 stimulation. The levels of TRIM29 expression were inversely correlated with IFN-γ production by NK cells, suggesting that TRIM29 inhibits NK cell functions. Indeed, deficiency of TRIM29, specifically in NK cells, resulted in an enhanced IFN-γ production and consequently protected mice from murine CMV infection. Mechanistically, we showed that once induced in NK cells, TRIM29 ubiquitinates and degrades the TGF-β–activated kinase 1 binding protein 2 (TAB2), a key adaptor protein in IFN-γ production by NK cells. These results identify TRIM29 as a negative regulator of NK cell functions and may have important clinical implications.
- 15 August 2019
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 203 (4) , 873-880
Open AccessIdentification of the E3 Ligase TRIM29 as a Critical Checkpoint Regulator of NK Cell Functions
NK cells play an important role in immune surveillance and protective immunity, mainly through rapid cytokine release and cytolytic activities. But how such responses are negatively regulated remains poorly defined. In this study, we demonstrated that the E3 ubiquitin ligase TRIM29 is a crucial regulator of NK cell functions. We found that TRIM29 was not expressed in resting NK cells, but was readily upregulated following activation, especially after IL-12 plus IL-18 stimulation. The levels of TRIM29 expression were inversely correlated with IFN-γ production by NK cells, suggesting that TRIM29 inhibits NK cell functions. Indeed, deficiency of TRIM29, specifically in NK cells, resulted in an enhanced IFN-γ production and consequently protected mice from murine CMV infection. Mechanistically, we showed that once induced in NK cells, TRIM29 ubiquitinates and degrades the TGF-β–activated kinase 1 binding protein 2 (TAB2), a key adaptor protein in IFN-γ production by NK cells. These results identify TRIM29 as a negative regulator of NK cell functions and may have important clinical implications.
- 12 March 2019
- Published by Springer Nature in Cellular & Molecular Immunology
- Vol. 16 (4) , 315-323
Transcriptional and epigenetic regulation of immune tolerance: roles of the NF-κB family members
Immune tolerance is a highly regulated state and involves diverse mechanisms. Central to the induction of tolerance is the targeted modulation of T-cell activities (both effector and regulatory), in which transcription factors play a significant role. The nuclear factor kappa-B (NF-κB) family is a family of transcription factors that not only are critically involved in diverse T-cell responses but also are regulated by many mechanisms to maintain tolerance and T-cell homeostasis. NF-κB, as a transcription factor, has been extensively studied in recent decades, and the molecular mechanisms that regulate NF-κB activities have been well documented. However, recent studies have revealed exciting new roles for NF-κB; in addition to its transcriptional activity, NF-κB can also activate diverse epigenetic mechanisms that mediate extensive chromatin remodeling of target genes to regulate T-cell activities. In this review article, we highlight recent discoveries and emerging opportunities in targeting NF-κB family members as well as their associated chromatin modifiers in the induction of immune tolerance and in the clinical treatment of immune diseases.
- 12 March 2019
- Published by Springer Nature in Cellular & Molecular Immunology
- Vol. 16 (4) , 315-323
Transcriptional and epigenetic regulation of immune tolerance: roles of the NF-κB family members
Immune tolerance is a highly regulated state and involves diverse mechanisms. Central to the induction of tolerance is the targeted modulation of T-cell activities (both effector and regulatory), in which transcription factors play a significant role. The nuclear factor kappa-B (NF-κB) family is a family of transcription factors that not only are critically involved in diverse T-cell responses but also are regulated by many mechanisms to maintain tolerance and T-cell homeostasis. NF-κB, as a transcription factor, has been extensively studied in recent decades, and the molecular mechanisms that regulate NF-κB activities have been well documented. However, recent studies have revealed exciting new roles for NF-κB; in addition to its transcriptional activity, NF-κB can also activate diverse epigenetic mechanisms that mediate extensive chromatin remodeling of target genes to regulate T-cell activities. In this review article, we highlight recent discoveries and emerging opportunities in targeting NF-κB family members as well as their associated chromatin modifiers in the induction of immune tolerance and in the clinical treatment of immune diseases.
- Open Access
- 23 November 2018
- Published by Elsevier in American Journal of Transplantation
- Vol. 19 (3) , 884-893
Ablation of interferon regulatory factor 4 in T cells induces “memory” of transplant tolerance that is irreversible by immune checkpoint blockade
- 23 November 2018
- Published by Elsevier in American Journal of Transplantation
- Vol. 19 (3) , 884-893
Open AccessAblation of interferon regulatory factor 4 in T cells induces “memory” of transplant tolerance that is irreversible by immune checkpoint blockade
- Open Access
- 1 July 2018
- Published by Elsevier in Cell Reports
- Vol. 24 (3) , 607-618
OX40 Costimulation Inhibits Foxp3 Expression and Treg Induction via BATF3-Dependent and Independent Mechanisms
- 1 July 2018
- Published by Elsevier in Cell Reports
- Vol. 24 (3) , 607-618
Open AccessOX40 Costimulation Inhibits Foxp3 Expression and Treg Induction via BATF3-Dependent and Independent Mechanisms